Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
or

Danaher Corp (DHR)

Danaher Corp (DHR)
197.12 x 1 206.00 x 3
Pre-market by (Cboe BZX)
200.39 -4.61 (-2.25%) 04/01/25 [NYSE]
197.12 x 1 206.00 x 3
Pre-market 198.75 -1.64 (-0.82%) 08:35 ET
Profile for Wed, Apr 2nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.

Company Info

Danaher Corp 2200 PENNSYLVANIA AVE. N.W SUITE 800W WASHINGTON DC 20037 USA

www.danaher.com Employees: 63,000 P: 202-828-0850 F: 202-828-0860

Sector:

Medical

Description:

Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally.

Key Statistics

Overview:

Market Capitalization, $K 143,220,736
Enterprise Value, $K 156,642,736
Shares Outstanding, K 714,710
Annual Sales, $ 23,875 M
Annual Net Income, $ 3,899 M
Last Quarter Sales, $ 6,538 M
Last Quarter Net Income, $ 1,086 M
EBIT, $ 4,863 M
EBITDA, $ 7,240 M
60-Month Beta 0.86
% of Insider Shareholders 11.10%
% of Institutional Shareholders 79.05%
Float, K 635,377
% Float 88.90%
Short Volume Ratio 0.37

Growth:

1-Year Return -19.19%
3-Year Return -24.47%
5-Year Return 55.11%
5-Year Revenue Growth 33.30%
5-Year Earnings Growth 69.23%
5-Year Dividend Growth 58.82%

Per-Share Information:

Most Recent Earnings 2.14 on 01/29/25
Next Earnings Date 04/22/25 [BMO]
Earnings Per Share ttm 7.49
EPS Growth vs. Prev Qtr 25.15%
EPS Growth vs. Prev Year 2.39%
Annual Dividend Rate, $ 1.28
Annual Dividend Yield 0.64%
Most Recent Dividend 0.320 on 03/28/25
Next Ex-Dividends Date 03/28/25
Dividend Payable Date 04/25/25
Dividend Payout Ratio 14.21%
Most Recent Split 141-125 on 10/02/23

DHR Ratios

Ratio
Price/Earnings ttm 27.37
Price/Earnings forward 26.95
Price/Earnings to Growth 2.63
Return-on-Equity % 10.82%
Return-on-Assets % 6.90%
Profit Margin % 16.33%
Debt/Equity 0.31
Price/Sales 6.14
Price/Cash Flow 18.84
Price/Book 3.00
Book Value/Share 68.60
Interest Coverage 17.71

DHR Dividends

Date Value
03/28/25 $0.3200
12/27/24 $0.2700
09/27/24 $0.2700
06/28/24 $0.2700
03/27/24 $0.2700
12/28/23 $0.2400
10/11/23 $0.2700
06/29/23 $0.2700
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies